NCT00675779

Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis

Comparison of Pain Relief and Inflammatory Status in Women With Surgically Confirmed Endometriosis Treated With Atorvastatin, Oral Contraceptive or Combined Oral Contraceptives and Atorvastatin: Open Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: Poznan University of Medical Sciences · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether atorvastatin (alone or in combination with oral contraceptive) is effective in treatment of pelvic pain and inflammatory response in women with endometriosis.

Conditions

• Endometriosis
• Pain

Interventions

Type	Name	Description
DRUG	oral contraceptive (Mercilon)	oral contraceptive (20ug EE, 150ug DSG) 1 tablet a day p.o. for 21 days with 7 day break for 6 months
DRUG	atorvastatin + oral contraceptive	atorvastatin 20mg po a day for 6 months + oral contraceptive (20ug EE, 150ug DSG) 1 tablet po a day for 21 days with 7 day break for 6 months

Timeline

• Start date: 2008-04-01
• Primary completion: 2010-11-01
• Completion: 2011-03-01
• First posted: 2008-05-12
• Last updated: 2008-05-12

Locations

1 site across 1 country: Poland